Targeting APP metabolism for the treatment of Alzheimer's disease
- 1 June 2002
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 56 (2), 211-227
- https://doi.org/10.1002/ddr.10077
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- A Presenilin 1 Mutation Associated with Familial Frontotemporal Dementia Inhibits γ-Secretase Cleavage of APP and NotchNeurobiology of Disease, 2002
- Glu11 Site Cleavage and N-Terminally Truncated Aβ Production upon BACE OverexpressionBiochemistry, 2002
- Functional role of TGFβ in Alzheimer's disease microvascular injury: lessons from transgenic miceNeurochemistry International, 2001
- Heparin promotes ß-secretase cleavage of the Alzheimer's amyloid precursor proteinNeurochemistry International, 1997
- Processing of Amyloid Precursor Protein in Human Primary Neuron and Astrocyte CulturesJournal of Neurochemistry, 1997
- Muscarinic m1 receptor agonists increase the secretion of the amyloid precursor protein ectodomainLife Sciences, 1997
- Study of the phorbol ester effect on Alzheimer amyloid precursor processing: Sequence requirements and involvement of a Cholera toxin sensitive proteinJournal of Neuroscience Research, 1994
- Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cellsNeuroscience Letters, 1991
- Modulation of metarhodopsin formation by cholesterol-induced ordering of bilayer lipidsBiochemistry, 1990
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984